Dasatrue 50 mg Tablet
$73,66
$54,09
Dasatrue 50 mg Tablet is a targeted anti-cancer treatment that features dasatinib as its active ingredient, specifically designed to combat certain hematological malignancies. This medication is primarily indicated for the treatment of chronic myeloid leukemia (CML), a serious condition characterized by the uncontrolled growth of white blood cells in the bone marrow. Dasatinib works by inhibiting specific proteins that contribute to cancer cell proliferation, thus helping to manage and control the progression of the disease. Patients should be aware of potential side effects, which may include fatigue, gastrointestinal issues, and fluid retention; regular monitoring by a healthcare professional is essential during treatment. It is crucial to inform your doctor about any existing health conditions or medications you are taking, as this can impact the effectiveness of Dasatrue. As with any cancer treatment, adherence to the prescribed regimen and routine follow-ups are vital for achieving optimal results. With its targeted action, Dasatrue 50 mg Tablet represents an important option for those battling CML, aiming to improve quality of life and treatment outcomes. Always consult with your healthcare provider to ensure this therapy aligns with your specific health needs.
數量
Active Pharmaceutical Ingredient
Uses
• Dasatrue 50 mg tablet is primarily indicated for the treatment of chronic myeloid leukemia (CML). This condition involves the overproduction of abnormal white blood cells in the bone marrow. Patients often experience symptoms such as fatigue, weakness, and an enlarged spleen. Dasatrue helps manage these symptoms by targeting the underlying disease process.
• Another important use of Dasatrue 50 mg tablet is in the management of acute lymphoblastic leukemia (ALL). This aggressive form of leukemia affects the white blood cells and can lead to rapid disease progression. Common symptoms include shortness of breath, easy bruising, and frequent infections. By utilizing Dasatrue, healthcare providers aim to control the disease and improve the overall quality of life for patients.
• Dasatrue 50 mg tablet is beneficial in treating both CML and ALL by inhibiting specific cancer cell growth. This targeted approach helps in reducing the number of abnormal cells in the bloodstream. As a result, patients may experience a reduction in symptoms associated with these leukemias. The use of Dasatrue is often part of a comprehensive treatment plan tailored to individual patient needs.
• In clinical practice, Dasatrue 50 mg tablet is prescribed to help achieve remission in patients with CML and ALL. Effective management of these conditions can lead to significant improvements in patient outcomes. Healthcare professionals may monitor the response to Dasatrue closely to ensure optimal therapeutic effects. This targeted therapy plays a crucial role in the ongoing management of leukemia patients.
Benefits
Dasatrue 50 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Dasatrue 50 mg Oral Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments. Dasatrue 50 mg is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Dasatrue Anti-cancer Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Dasatinib 50 mg Tablet may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dasatrue 50 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Dasatrue 50 mg Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Dasatrue 50 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Dasatrue 50 mg Oral Tablet. Dasatrue 50 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Dasatrue Anti-cancer Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dasatrue 50 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Dasatrue 50 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Dasatinib 50 mg Tablet may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Dasatrue 50 mg may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dasatrue Anti-cancer Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dasatrue 50 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Dasatrue Cancer Medicine.